Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7853da4eaae345c2317290e37087f1f3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aba44e2f22fd216481bc4c2b20767c85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8704f153ad5787446bc3fb3c7d6b2d2a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37dcf30136a4a1ca40f9bbb4b80584b4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d59b1133e9f5ddc721ab1f41f0f23ec |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-216 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-42 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-047 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07G11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-00 |
filingDate |
2010-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c050a13b14fab33637887688c68f1aaf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39b4ea3bfa626d8357ce7f9ac8f6f5d5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15fc8084264b74b6ad55e9342e29797e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ad78c4b8254630cfb5e2f82c20ba851 |
publicationDate |
2010-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2010088192-A1 |
titleOfInvention |
Bacteriostatic catheter lock containing glycerol |
abstract |
A catheter lock composition for preventing bacterial infection having an effective amount of glycerol and sodium chloride solution. The effective amount of glycerol is between about 35-60% and sodium chloride is in a concentration range between 0.5-0.9%. The composition further includes an anticoagulant and/or an antimicrobial agent. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11045589-B2 |
priorityDate |
2009-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |